-
Gemigliptin (rINN), sold
under the
brand name
Zemiglo, is an oral anti-hyperglycemic
agent (anti-diabetic drug) of the
dipeptidyl peptidase-4 inhibitor...
- (approved in
Korea in 2012,
marketed by LG Life Sciences)
Marketed as
Zemiglo Anagliptin (approved in ****an as
Suiny in 2012,
marketed by
Sanwa Kagaku...
- of
multiple FDA-approved medicines,
including alogliptin, trelagliptin,
Zemiglo (Zemdi), Zemdri, and Kybella.
David earned an A.B. in
Biology from Harvard...
-
Approved May 2, 2011
alogliptin septagliptin teneligliptin gemigliptin (
Zemiglo) DPP-4
inhibitors lowered hemoglobin A1C
values by 0.74%,
comparable to...
